RPHM Annual SG&A
$26.44 M
+$10.30 M+63.79%
31 December 2023
Summary:
As of January 27, 2025, RPHM annual selling, general & administrative expenses is $26.44 million, with the most recent change of +$10.30 million (+63.79%) on December 31, 2023. During the last 3 years, it has risen by +$22.83 million (+632.82%).RPHM Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RPHM Quarterly SG&A
$5.77 M
+$1.15 M+24.92%
30 June 2024
Summary:
As of January 27, 2025, RPHM quarterly selling, general & administrative expenses is $5.77 million, with the most recent change of +$1.15 million (+24.92%) on June 30, 2024. Over the past year, it has dropped by -$1.63 million (-21.99%).RPHM Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RPHM TTM SG&A
-$868.15 M
-$60.94 M-7.55%
30 June 2024
Summary:
As of January 27, 2025, RPHM TTM selling, general & administrative expenses is -$868.15 million, with the most recent change of -$60.94 million (-7.55%) on June 30, 2024. Over the past year, it has dropped by -$894.59 million (-3383.60%).RPHM TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RPHM Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +63.8% | -22.0% | -3383.6% |
| 3 y3 years | +632.8% | +34.3% | -5890.0% |
| 5 y5 years | +1012.8% | +231.5% | -10000.0% |
RPHM Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | at high | -22.0% | -3383.6% |
Reneo Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | $5.77 M(+24.9%) | $25.06 M(-3.3%) |
| Mar 2024 | - | $4.62 M(-37.6%) | $25.93 M(-1.9%) |
| Dec 2023 | $26.44 M(+63.8%) | $7.40 M(+1.9%) | $26.44 M(+13.8%) |
| Sept 2023 | - | $7.27 M(+9.4%) | $23.24 M(+16.9%) |
| June 2023 | - | $6.64 M(+29.4%) | $19.88 M(+13.3%) |
| Mar 2023 | - | $5.13 M(+22.0%) | $17.54 M(+8.6%) |
| Dec 2022 | $16.14 M(+38.6%) | $4.21 M(+7.8%) | $16.14 M(+4.4%) |
| Sept 2022 | - | $3.90 M(-9.2%) | $15.46 M(+3.1%) |
| June 2022 | - | $4.30 M(+15.0%) | $14.99 M(+9.9%) |
| Mar 2022 | - | $3.74 M(+6.0%) | $13.64 M(+17.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $11.65 M(+222.9%) | $3.52 M(+2.6%) | $11.65 M(+25.8%) |
| Sept 2021 | - | $3.43 M(+16.4%) | $9.26 M(+42.6%) |
| June 2021 | - | $2.95 M(+69.3%) | $6.49 M(+46.7%) |
| Mar 2021 | - | $1.74 M(+53.8%) | $4.42 M(+22.7%) |
| Dec 2020 | $3.61 M(+51.9%) | - | - |
| Dec 2020 | - | $1.13 M(+69.6%) | $3.61 M(+45.8%) |
| Sept 2020 | - | $668.00 K(-24.3%) | $2.47 M(+37.0%) |
| June 2020 | - | $882.00 K(-4.5%) | $1.81 M(+95.5%) |
| Mar 2020 | - | $924.00 K | $924.00 K |
| Dec 2019 | $2.38 M | - | - |
FAQ
- What is Reneo Pharmaceuticals annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Reneo Pharmaceuticals?
- What is Reneo Pharmaceuticals annual SG&A year-on-year change?
- What is Reneo Pharmaceuticals quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Reneo Pharmaceuticals?
- What is Reneo Pharmaceuticals quarterly SG&A year-on-year change?
- What is Reneo Pharmaceuticals TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Reneo Pharmaceuticals?
- What is Reneo Pharmaceuticals TTM SG&A year-on-year change?
What is Reneo Pharmaceuticals annual selling, general & administrative expenses?
The current annual SG&A of RPHM is $26.44 M
What is the all time high annual SG&A for Reneo Pharmaceuticals?
Reneo Pharmaceuticals all-time high annual selling, general & administrative expenses is $26.44 M
What is Reneo Pharmaceuticals annual SG&A year-on-year change?
Over the past year, RPHM annual selling, general & administrative expenses has changed by +$10.30 M (+63.79%)
What is Reneo Pharmaceuticals quarterly selling, general & administrative expenses?
The current quarterly SG&A of RPHM is $5.77 M
What is the all time high quarterly SG&A for Reneo Pharmaceuticals?
Reneo Pharmaceuticals all-time high quarterly selling, general & administrative expenses is $7.40 M
What is Reneo Pharmaceuticals quarterly SG&A year-on-year change?
Over the past year, RPHM quarterly selling, general & administrative expenses has changed by -$1.63 M (-21.99%)
What is Reneo Pharmaceuticals TTM selling, general & administrative expenses?
The current TTM SG&A of RPHM is -$868.15 M
What is the all time high TTM SG&A for Reneo Pharmaceuticals?
Reneo Pharmaceuticals all-time high TTM selling, general & administrative expenses is $26.44 M
What is Reneo Pharmaceuticals TTM SG&A year-on-year change?
Over the past year, RPHM TTM selling, general & administrative expenses has changed by -$894.59 M (-3383.60%)